ACTIVE

RevaTis

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-620,7 k €

-136.9% YoY

Gross margin

136,6 k €

-77.5% YoY

Equity

2,6 M €

+3.1% YoY

What does RevaTis do?

RevaTis is a Public limited company incorporated in 2013. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Marche-en-Famenne.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0541.682.642

Incorporation

06/11/2013

Legal form

Public limited company

Registered office

Aye, Rue de la Science 8
6900 Marche-en-Famenne · WallonieSee on map

Contributed capital

4 210 000,00 €

Latest accounts

31/12/2025

Activities (NACE)

21201Manufacture of pharmaceutical preparations· main 21201Manufacture of pharmaceutical preparations 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods+2

Joint committees (1)

Signals

Solid equityHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 12 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014
Income statement
Gross margin	136,6 k €	-77.5%	606,8 k €	+4.2%	582,3 k €	-15.4%	688,2 k €	+30.0%	529,5 k €	-19.3%	655,9 k €	+519%	106,0 k €	+582%	15,5 k €	-93.9%	256,3 k €	+246%	74,1 k €	+202%	-72,6 k €	+51.0%	-148,1 k €
EBITDA	-280,7 k €	-345%	114,4 k €	-22.9%	148,3 k €	-57.3%	347,6 k €	+22.5%	283,8 k €	-43.3%	500,6 k €	+1063%	-52,0 k €	+62.3%	-137,7 k €	-242%	96,8 k €	+188%	-109,9 k €	+16.9%	-132,2 k €	+21.6%	-168,5 k €
Operating result	-590,1 k €	-148%	-237,9 k €	-18.3%	-201,2 k €	-342%	83,2 k €	+24.2%	67,0 k €	-77.0%	291,6 k €	+198%	-296,5 k €	+13.1%	-341,2 k €	-1058%	-29,5 k €	+81.7%	-161,2 k €	-13.1%	-142,6 k €	+32.4%	-211,0 k €
Net result	-620,7 k €	-137%	-262,0 k €	-17.9%	-222,3 k €	-561%	48,3 k €	-17.6%	58,5 k €	-79.2%	281,5 k €	+192%	-304,6 k €	+13.5%	-352,2 k €	-889%	-35,6 k €	+78.1%	-162,8 k €	-21.9%	-133,6 k €	+30.5%	-192,3 k €
Balance sheet
Equity	2,6 M €	+3.1%	2,5 M €	-9.6%	2,7 M €	+10.1%	2,5 M €	+64.0%	1,5 M €	+4.0%	1,5 M €	+153%	576,3 k €	-34.3%	877,4 k €	+43.7%	610,6 k €	+76.6%	345,8 k €	+32.9%	260,1 k €	+12.3%	231,7 k €
Total assets	4,1 M €	+13.1%	3,6 M €	-5.1%	3,8 M €	+8.8%	3,5 M €	+32.8%	2,7 M €	+6.6%	2,5 M €	+38.3%	1,8 M €	-7.1%	1,9 M €	+36.0%	1,4 M €	+38.0%	1,0 M €	+180%	368,3 k €	+54.1%	238,9 k €
Cash	371,7 k €	+45.5%	255,4 k €	-31.2%	371,3 k €	-18.2%	454,1 k €	+8.4%	418,9 k €	-44.0%	748,3 k €	+655%	99,1 k €	-75.5%	404,7 k €	+12.7%	359,2 k €	+82.4%	196,9 k €	+116%	91,3 k €	+261%	25,3 k €
Debts	1,6 M €	+34.3%	1,2 M €	+6.2%	1,1 M €	+5.9%	1,0 M €	-8.9%	1,1 M €	+10.2%	1,0 M €	-15.6%	1,2 M €	+15.3%	1,1 M €	+30.3%	813,4 k €	+18.5%	686,4 k €	+535%	108,1 k €	+1401%	7,2 k €
Other
Workforce	–		5,7 ETP	+1.8%	5,6 ETP		–		–		–		–		–		–		–		1,4 ETP	+100%	0,7 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 12 active · 34 ended

Active mandates

Alexandre DALLEMAGNE

Director

Active

Didier SERTEYN

Director

Active

Jacques KUYPERS

Director

Active

Jean-Claude HAVAUX

Director

Active

Jean-Loup BLONDEAU

Director

Active

Jean-Luc MARTIN

Director

Active

Jean-Paul LACOMBLE

Director

Active

Joseph MARTIAL

Director

Active

LUXEMBOURG DEVELOPPEMENT EUROPE DEUX

Director · 0670.937.716

Active

NOSHAQ PARTNERS

Director · 0808.219.836

Represented by Frédéric SCHYNTS

Active

Philippe NEVEN

Director

Active

salamander U

Director · 0640.885.928

Represented by Jean-Claude DEDRY

Active

Ended mandates

Jacques KUYPERS

Director · since 19 septembre 2020 · until 15 juin 2026

Ended

Alexandre DALLEMAGNE

Director · since 19 juin 2020 · until 15 juin 2026

Ended

Didier SERTEYN

Managing director · since 19 juin 2020 · until 15 juin 2026

Ended

Jacques KUYPERS

Director · since 19 juin 2020 · until 15 juin 2026

Ended

At this address

Other companies at this address

Company	CBE no.
AGRICELLS● Active	0742.991.393
Association pour le développement des Productions Agroalimentaires de qualité● Active	0416.914.413
Association pour l'Usage et la Défense de l'Appellation Jambon d'Ardenne● Active	0457.901.762
ASSOCIATION POUR L'USAGE ET LA DEFENSE DU SAUCISSON D'ARDENNE● Active	0863.356.814
ATB THERAPEUTICS● Active	0677.980.015
Bureau d’Administration ATB THERAPEUTICS● Active	1031.100.991
CER-Groupe● Active	0420.654.158
INVESTY CORPORATE● Active	1008.960.841
Orgenesis (Belgium)● Bankrupt	0540.866.555
ORGENESIS SERVICES SRL● Bankrupt	0790.353.624
REVATIS VET● Active	1015.868.627
THERACELL ADVANCED BIOTECHNOLOGY (Belgium)● Active	0731.712.273

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Abridged model	Abridged model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/07/2026	12/11/2025	29/07/2024	12/07/2023	06/07/2022	31/08/2021
General meeting	12/06/2026	13/06/2025	14/06/2024	09/06/2023	10/06/2022	11/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

12 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	12/06/2026	28/07/2026	French	PDF
Abridged model	31/12/2024	13/06/2025	12/11/2025	French	PDF
Abridged model	31/12/2023	14/06/2024	29/07/2024	French	PDF
Micro model	31/12/2022	09/06/2023	12/07/2023	French	PDF
Micro model	31/12/2021	10/06/2022	06/07/2022	French	PDF
Micro model	31/12/2020	11/06/2021	31/08/2021	French	PDF
Micro model	31/12/2019	19/06/2020	09/07/2020	French	PDF
Micro model	31/12/2018	11/06/2019	01/07/2019	French	PDF
Micro model	31/12/2017	08/06/2018	05/07/2018	French	PDF
Micro model	31/12/2016	13/06/2017	12/07/2017	French	PDF
Abridged model	31/12/2015	07/06/2016	08/07/2016	French	PDF
Abridged model	31/12/2014	12/06/2015	15/07/2015	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 12 active · 34 ended

Active mandates

Alexandre DALLEMAGNE

Director

Active

Didier SERTEYN

Director

Active

Jacques KUYPERS

Director

Active

Jean-Claude HAVAUX

Director

Active

Jean-Loup BLONDEAU

Director

Active

Jean-Luc MARTIN

Director

Active

Jean-Paul LACOMBLE

Director

Active

Joseph MARTIAL

Director

Active

LUXEMBOURG DEVELOPPEMENT EUROPE DEUX

Director · 0670.937.716

Active

NOSHAQ PARTNERS

Director · 0808.219.836

Represented by Frédéric SCHYNTS

Active

Philippe NEVEN

Director

Active

salamander U

Director · 0640.885.928

Represented by Jean-Claude DEDRY

Active

Ended mandates

Jacques KUYPERS

Director · since 19 septembre 2020 · until 15 juin 2026

Ended

Alexandre DALLEMAGNE

Director · since 19 juin 2020 · until 15 juin 2026

Ended

Didier SERTEYN

Managing director · since 19 juin 2020 · until 15 juin 2026

Ended

Jacques KUYPERS

Director · since 19 juin 2020 · until 15 juin 2026

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates30/10/2025
DEMISSIONS, NOMINATIONS
PDF
Capital / shares23/09/2025
CAPITAL, ACTIONS
PDF
Mandates22/04/2025
CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Capital / shares27/01/2025
CAPITAL, ACTIONS
PDF
Mandates22/11/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates07/08/2023
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Mandates26/07/2023
DEMISSIONS, NOMINATIONS
PDF
Capital / shares13/07/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-620,7 k €↓
2024
Annual accounts 2024-262,0 k €↓
2023
Annual accounts 2023-222,3 k €↓
2022
Annual accounts 202248,3 k €↓
2021
Annual accounts 202158,5 k €↓
2020
Annual accounts 2020281,5 k €↑
2019
Annual accounts 2019-304,6 k €↑
2018
Annual accounts 2018-352,2 k €↓
2017
Annual accounts 2017-35,6 k €↑
2016
Annual accounts 2016-162,8 k €↓
2015
Annual accounts 2015-133,6 k €↑
2014
Annual accounts 2014-192,3 k €
06/11/2013
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

RevaTis

Overview

What does RevaTis do?

Trend over 12 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline